Abstract
Proteins can undergo a variety of conformational changes upon ligand binding. Although different mechanisms may play a role, the phenomenon is commonly referred to as induced fit to indicate that the tight structural complementarity of the interaction partners is a consequence of the binding event. Docking methods need to take into account this ability of the ligand and the protein to mutually adapt to each other when forming a complex. Handling the ligand as flexible is already common practice in docking applications. This is not yet the case for the protein. In fact, the accurate prediction of protein conformational changes upon ligand binding is still a major challenge, even more if computational speed is an issue, as for example in virtual screening applications. However, significant progress has been made over the past years and many valuable approaches have become available to address the protein flexibility problem and to provide more reliable docking predictions for complexes governed by significant induced-fit effects. This review provides a brief overview of the current situation, the most recent advances, and the remaining limitations of flexible protein docking, with particular focus on approaches handling protein flexibility simultaneously with ligand placement in the docking process.
Keywords: Protein flexibility, conformational changes, induced fit, structure-based drug design, docking, scoring, protein-ligand complexes, ligand binding, NMR, PDB, enzymes, substrate binding, conformational selection, NADPH, cofactor, induced conformational change, 3D structures, RosettaLigand, flexibility, optimization, SLIDE, algorithms, ICM method, FlexX, GOLD, IFD, MRC docking, NMR data, DOCK, AutoDock, MD, FlexE, LMOD, domain, Gibbs free energy, entropic, enthalpic, AR, Leu300, Cys298-Leu300, X-ray crystallography, Trp20, Lys21, aldose reductase, TGT, MCM, ROSETTA, RMSD, SAMPL-1, JNK3, TAMD, MAP, ICM, MRC, EN NMA, SCARE, MADAMM, CHARMM, LGA, FITTED, CYP2D6, SOM, SA, FlexScreen, DUD, ChiFlex, CDOCKER, CDK2
Current Topics in Medicinal Chemistry
Title: Accounting for Induced-Fit Effects in Docking: What is Possible and What is Not?
Volume: 11 Issue: 2
Author(s): Christoph A. Sotriffer
Affiliation:
Keywords: Protein flexibility, conformational changes, induced fit, structure-based drug design, docking, scoring, protein-ligand complexes, ligand binding, NMR, PDB, enzymes, substrate binding, conformational selection, NADPH, cofactor, induced conformational change, 3D structures, RosettaLigand, flexibility, optimization, SLIDE, algorithms, ICM method, FlexX, GOLD, IFD, MRC docking, NMR data, DOCK, AutoDock, MD, FlexE, LMOD, domain, Gibbs free energy, entropic, enthalpic, AR, Leu300, Cys298-Leu300, X-ray crystallography, Trp20, Lys21, aldose reductase, TGT, MCM, ROSETTA, RMSD, SAMPL-1, JNK3, TAMD, MAP, ICM, MRC, EN NMA, SCARE, MADAMM, CHARMM, LGA, FITTED, CYP2D6, SOM, SA, FlexScreen, DUD, ChiFlex, CDOCKER, CDK2
Abstract: Proteins can undergo a variety of conformational changes upon ligand binding. Although different mechanisms may play a role, the phenomenon is commonly referred to as induced fit to indicate that the tight structural complementarity of the interaction partners is a consequence of the binding event. Docking methods need to take into account this ability of the ligand and the protein to mutually adapt to each other when forming a complex. Handling the ligand as flexible is already common practice in docking applications. This is not yet the case for the protein. In fact, the accurate prediction of protein conformational changes upon ligand binding is still a major challenge, even more if computational speed is an issue, as for example in virtual screening applications. However, significant progress has been made over the past years and many valuable approaches have become available to address the protein flexibility problem and to provide more reliable docking predictions for complexes governed by significant induced-fit effects. This review provides a brief overview of the current situation, the most recent advances, and the remaining limitations of flexible protein docking, with particular focus on approaches handling protein flexibility simultaneously with ligand placement in the docking process.
Export Options
About this article
Cite this article as:
A. Sotriffer Christoph, Accounting for Induced-Fit Effects in Docking: What is Possible and What is Not?, Current Topics in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/156802611794863544
DOI https://dx.doi.org/10.2174/156802611794863544 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Valosin Containing Protein Associated Fronto-Temporal Lobar Degeneration:Clinical Presentation, Pathologic Features and Pathogenesis
Current Alzheimer Research Nutritional Overview on the Management of Type 2 Diabetes and the Prevention of its Complications
Current Diabetes Reviews Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry Spinal Cord Injury Changes Cytokine Transport
CNS & Neurological Disorders - Drug Targets Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases
Current Pharmaceutical Design Kinin Receptors in Vascular Biology and Pathology
Current Vascular Pharmacology Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer’s Disease: A Study of EEG-Derived Brain Activity
Current Alzheimer Research The Interaction of DNA-Binding Ligands with Trinucleotide-Repeat DNA: Implications for Therapy and Diagnosis of Neurological Disorders
Current Topics in Medicinal Chemistry Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
Current Medicinal Chemistry GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies
CNS & Neurological Disorders - Drug Targets Emerging Potential of Natural Products as an Alternative Strategy to Pharmacological Agents Used Against Metabolic Disorders
Current Drug Metabolism Biological Mechanisms Linking Alzheimer's Disease and Type-2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Emerging Potential of Citrus Flavanones as an Antioxidant in Diabetes and its Complications
Current Topics in Medicinal Chemistry Frontotemporal Dementia Caused by CHMP2B Mutations
Current Alzheimer Research Inflammatory Caspases: Targets for Novel Therapies
Current Pharmaceutical Design Neuroprotective Role of Natural Polyphenols
Current Topics in Medicinal Chemistry Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design Protective Role of Diabetes Mellitus on Abdominal Aortic Aneurysm Pathogenesis: Myth or Reality?
Current Vascular Pharmacology GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System
Current Pharmaceutical Design Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets